STOCK TITAN

DelphX Announces Non-Brokered Unit Private Placement

(Very High)
(Neutral)
Tags
private placement

DelphX Capital Markets (OTCQB: DPXCF, TSXV: DELX) has commenced a non-brokered private placement of up to 5,000,000 units at C$0.01 per unit, for potential gross proceeds of up to C$50,000. Each unit includes one common share and one warrant exercisable at C$0.06 for two years.

DelphX may pay finder's fees in line with TSX Venture policies and plans to use net proceeds mainly for working capital and corporate overhead, with no more than 10% for investor relations. The financing is subject to TSX Venture Exchange approval and the securities will carry a four-month-plus-one-day hold period and the Exchange Hold Period.

Loading...
Loading translation...

Positive

  • Non-brokered unit offering for up to C$50,000 gross proceeds
  • Low unit price of C$0.01 may ease participation
  • Two-year warrants at C$0.06 add potential upside for investors
  • Cap of 10% of proceeds for investor relations spending

Negative

  • Issuance of up to 5,000,000 new shares and warrants may dilute holders
  • Offering completion remains subject to TSX Venture Exchange approval
  • Securities subject to a hold period of four months plus one day

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

Toronto, Ontario and New York, New York--(Newsfile Corp. - August 20, 2026) - DelphX Capital Markets Inc. (TSXV: DELX) (OTCQB: DPXCF) ("DelphX" or the "Company"), a leader in the development of new classes of structured products, announces that it has commenced a non-brokered private placement of up to 5,000,000 units of the Company (the "Units") at a subscription price of C$0.01 per Unit, for gross proceeds of up to C$50,000 (the "Offering").

Each Unit consists of one common share of the Company (a "Common Share") and one Common Share purchase warrant (a "Warrant"). Each Warrant entitles the holder to purchase one additional Common Share at an exercise price of C$0.06 for a period of two years from the date of issuance.

In connection with the Offering, DelphX may elect to pay finder's fees to eligible finders in accordance with the policies of the TSX Venture Exchange. Details of any finder's fees paid will be announced at a later date.

DelphX intends to use the net proceeds of the Offering for working capital and corporate overhead. No more than 10% of the gross proceeds of the Offering will be used to fund investor relations activities.

Completion of the Offering is subject to the approval of the TSX Venture Exchange. The securities issued pursuant to the Offering will be subject to a hold period of four months plus one day from the date of issuance and, as the Units are priced at less than C$0.05 per Unit, will be subject to the Exchange Hold Period and legended accordingly.

About DelphX Capital Markets Inc.

DelphX is a technology and financial services company focused on developing and distributing the next generation of structured products. Through its special purpose vehicle Quantem LLC, the Company enables broker dealers to offer new private placement securities that provide for both fixed income and cryptocurrency solutions. The new DelphX securities will enable dealers and their qualified institutional investors (QIBs) accounts to competitively structure, sell and make markets in:

  • Collateralized put options (CPOs) that provide secured rating downgrade protection for underlying corporate bonds and/or protection from losses in cryptocurrency holdings;

  • Collateralized reference notes (CRNs) that enable investors to take on a capped rating downgrade and/or cryptocurrency loss exposure of an underlying security or cryptocurrency in exchange for attractive returns.

All CPOs and CRNs are fully collateralized and held in custody by US Bank. CPOs and CRNs are proprietary products created and owned by DelphX Capital Markets.

For more information about DelphX, please visit www.delphx.com.

For further information, please contact:

George Wentworth, General Manager
DelphX Capital Markets Inc.
george.wentworth@delphx.com
(718) 509-2160

Forward-Looking Statements

This news release contains "forward-looking information" within the meaning of applicable Canadian securities laws, including statements regarding the proposed non-brokered private placement, the anticipated gross proceeds and the intended use of proceeds. Forward-looking information is based on the Company's current expectations and assumptions and is subject to risks and uncertainties that could cause actual results to differ materially, including the risk that the Offering is not completed on the terms contemplated or at all, that the Offering is not fully subscribed, or that regulatory approval from the TSX Venture Exchange is not obtained. Readers are cautioned not to place undue reliance on forward-looking information, which speaks only as of the date of this release. The Company undertakes no obligation to update such information except as required by law.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/310679

FAQ

What is DelphX (OTCQB: DPXCF) announcing in its August 20, 2026 financing?

DelphX announced a non-brokered private placement of up to 5,000,000 units at C$0.01 per unit, for gross proceeds up to C$50,000. According to DelphX, each unit contains one common share and one two-year warrant exercisable at C$0.06.

What are the terms of the new DelphX DPXCF private placement units?

Each DelphX unit consists of one common share and one common share purchase warrant. According to DelphX, each warrant allows the holder to buy one additional share at C$0.06 for two years from issuance, with units priced at C$0.01 each.

How will DelphX use the proceeds from the DPXCF private placement?

DelphX plans to use net proceeds primarily for working capital and corporate overhead. According to DelphX, no more than 10% of the gross proceeds from the offering will be allocated to investor relations activities, indicating a focus on operational funding needs.

Is the DelphX (TSXV: DELX) private placement subject to any regulatory approvals?

Yes, completion of the DelphX private placement is subject to approval from the TSX Venture Exchange. According to DelphX, securities issued will also be subject to a four-month-plus-one-day hold period and an additional Exchange Hold Period due to pricing below C$0.05.

Will the DelphX DPXCF private placement cause dilution for existing shareholders?

The offering could dilute existing shareholders because it includes up to 5,000,000 new shares plus related warrants. According to DelphX, each unit has one share and one warrant, which may later convert into additional shares if exercised.

Are there any resale restrictions on the new DelphX (DPXCF) securities?

Yes, the securities from this offering will be subject to a hold period of four months plus one day from issuance. According to DelphX, because the units are priced below C$0.05, they will also be subject to the TSX Venture Exchange Hold Period with appropriate legends.